BRPI0821619A2 - Método para preparação de um compolímero de bloco anfifílico, copolímero de bloco anfifílico e composição farmacêutica compreendendo este - Google Patents

Método para preparação de um compolímero de bloco anfifílico, copolímero de bloco anfifílico e composição farmacêutica compreendendo este

Info

Publication number
BRPI0821619A2
BRPI0821619A2 BRPI0821619-3A BRPI0821619A BRPI0821619A2 BR PI0821619 A2 BRPI0821619 A2 BR PI0821619A2 BR PI0821619 A BRPI0821619 A BR PI0821619A BR PI0821619 A2 BRPI0821619 A2 BR PI0821619A2
Authority
BR
Brazil
Prior art keywords
amphiphilic block
preparing
pharmaceutical composition
compolymer
block copolymer
Prior art date
Application number
BRPI0821619-3A
Other languages
English (en)
Inventor
Bong Oh Kim
Myung Seob Shim
Min-Hyo Seo
Original Assignee
Samyang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Corp filed Critical Samyang Corp
Publication of BRPI0821619A2 publication Critical patent/BRPI0821619A2/pt
Publication of BRPI0821619B1 publication Critical patent/BRPI0821619B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88—Post-polymerisation treatment
    • C08G63/90—Purification; Drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10—Definition of the polymer structure
    • C08G2261/12—Copolymers
    • C08G2261/126—Copolymers block
BRPI0821619A 2007-12-31 2008-12-31 método para preparação de um copolímero de bloco anfifílico BRPI0821619B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20070141165 2007-12-31
PCT/KR2008/007854 WO2009091150A2 (en) 2007-12-31 2008-12-31 Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof

Publications (2)

Publication Number Publication Date
BRPI0821619A2 true BRPI0821619A2 (pt) 2015-06-16
BRPI0821619B1 BRPI0821619B1 (pt) 2018-12-18

Family

ID=40885775

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821619A BRPI0821619B1 (pt) 2007-12-31 2008-12-31 método para preparação de um copolímero de bloco anfifílico

Country Status (10)

Country Link
US (1) US8853351B2 (pt)
EP (1) EP2229417B1 (pt)
JP (1) JP5576291B2 (pt)
KR (1) KR101187487B1 (pt)
CN (1) CN101910246B (pt)
AU (1) AU2008347720C1 (pt)
BR (1) BRPI0821619B1 (pt)
CA (1) CA2709967C (pt)
RU (1) RU2459840C2 (pt)
WO (1) WO2009091150A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8450337B2 (en) 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
KR101236198B1 (ko) 2011-02-08 2013-02-22 아주대학교산학협력단 생체 작용 관능기가 곁사슬에 도입된 온도감응성 폴리에틸렌글리콜/폴리에스터 블록 공중합체 및 이의 제조방법
RU2527471C1 (ru) * 2013-04-19 2014-08-27 Федеральное государственное унитарное предприятие "Научно-исследовательский институт химии и технологии полимеров имени академика В.А. Каргина с опытным заводом" (ФГУП "НИИ полимеров") Полиэфирполикарбонаты олигомолочной кислоты
US9187605B2 (en) * 2013-07-18 2015-11-17 Xerox Corporation Process to prepare polyester phase inversion latexes
KR101745429B1 (ko) * 2015-07-28 2017-06-12 주식회사 삼양바이오팜 양친성 블록 공중합체의 정제방법, 이로부터 얻어지는 양친성 블록 공중합체, 및 이를 포함하는 약학 조성물
KR101787453B1 (ko) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
KR101748191B1 (ko) * 2015-07-28 2017-06-19 주식회사 삼양바이오팜 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
KR101787447B1 (ko) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
KR101787451B1 (ko) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법
US20170028068A1 (en) * 2015-07-29 2017-02-02 Samyang Biopharmaceuticals Corporation Pharmaceutical composition with improved storage stability and method for preparing the same
WO2018110870A1 (ko) 2016-12-14 2018-06-21 주식회사 삼양바이오팜 미셀 안정성이 향상된 양친성 블록 공중합체 조성물 및 이를 포함하는 약학 조성물
US20190231689A1 (en) * 2018-01-29 2019-08-01 Samyang Biopharmaceuticals Corporation Amphiphilic Block Copolymer Composition With Enhanced Micelle Stability
CN110373762B (zh) * 2019-05-10 2022-04-12 海盐县硕创服装研究所 内衣用抗菌混纺纱的制备方法
CN114891222B (zh) * 2022-07-01 2023-09-26 华南理工大学 一种分子量不连续的聚（n-取代）二硫代氨基甲酸酯类化合物及其制备方法与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1685952A1 (ru) * 1989-04-12 1991-10-23 Предприятие П/Я А-7629 Способ получени сложных полиэфиров
MY108621A (en) * 1990-08-01 1996-10-31 Novartis Ag Polylactide preparation and purification
US6353030B1 (en) * 1990-08-01 2002-03-05 Novartis Ag Relating to organic compounds
JP3365422B2 (ja) * 1992-07-28 2003-01-14 三菱化学株式会社 高純度ポリグリセリン脂肪酸エステルの製造方法
US5338822A (en) * 1992-10-02 1994-08-16 Cargill, Incorporated Melt-stable lactide polymer composition and process for manufacture thereof
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
KR100446101B1 (ko) * 2000-12-07 2004-08-30 주식회사 삼양사 수난용성 약물의 서방성 제형 조성물
CN100378140C (zh) * 2001-06-20 2008-04-02 日本化药株式会社 杂质量降低的嵌段共聚物、聚合载体、呈聚合形式的药物制剂及其制备方法
US6592899B2 (en) * 2001-10-03 2003-07-15 Macromed Incorporated PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
CA2463517C (en) * 2001-10-18 2010-03-16 Samyang Corporation Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery
CA2463172C (en) * 2001-10-18 2009-08-18 Samyang Corporation Polymeric micelle composition with improved stability
WO2005035606A1 (en) * 2003-10-10 2005-04-21 Samyang Corporation Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
KR100601671B1 (ko) * 2004-04-13 2006-07-14 삼성전자주식회사 복사 금지된 콘텐츠의 예약 녹화 방법
AU2005238511A1 (en) 2004-04-23 2005-11-10 Amgen Inc. Low molecular weight polylactic acid polymers
JP4659451B2 (ja) * 2004-12-28 2011-03-30 グンゼ株式会社 金属触媒の含有量が少ない生体内分解吸収性高分子及びその製法
DE102005033101A1 (de) * 2005-07-15 2007-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Resorbierbare Polyetherester und ihre Verwendung zur Herstellung von medizinischen Implantaten
JP2007070413A (ja) * 2005-09-05 2007-03-22 Teijin Ltd ポリ乳酸組成物およびその製造方法
JP4957001B2 (ja) * 2006-01-30 2012-06-20 日油株式会社 末端アルケニル基含有ポリオキシアルキレンステロール誘導体の製造方法

Also Published As

Publication number Publication date
KR20100097144A (ko) 2010-09-02
WO2009091150A2 (en) 2009-07-23
BRPI0821619B1 (pt) 2018-12-18
RU2459840C2 (ru) 2012-08-27
KR101187487B1 (ko) 2012-10-02
AU2008347720B2 (en) 2011-07-28
JP5576291B2 (ja) 2014-08-20
CA2709967A1 (en) 2009-07-23
JP2011508046A (ja) 2011-03-10
EP2229417B1 (en) 2014-07-30
AU2008347720A1 (en) 2009-07-23
CA2709967C (en) 2012-05-29
RU2010130423A (ru) 2012-02-10
AU2008347720C1 (en) 2012-01-19
US8853351B2 (en) 2014-10-07
EP2229417A4 (en) 2011-06-22
CN101910246B (zh) 2013-01-02
EP2229417A2 (en) 2010-09-22
WO2009091150A3 (en) 2009-10-22
US20100280214A1 (en) 2010-11-04
CN101910246A (zh) 2010-12-08

Similar Documents

Publication Publication Date Title
BRPI0821619A2 (pt) Método para preparação de um compolímero de bloco anfifílico, copolímero de bloco anfifílico e composição farmacêutica compreendendo este
BRPI0718974A2 (pt) Copolímero, e, método para preparar um copolímero
BRPI0917358A2 (pt) formulação farmacêutica de liberação controlada e método.
BRPI0808034A2 (pt) Método para produzir hidrocloreto de prasugrel, hidrocloreto de prasugrel, composição farmacêutica, e, uso de um hidrocloreto de prasugrel.
BRPI0816318A2 (pt) Dispositivo de liberação transdérmica, e, método para preparar o mesmo
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI0912194A2 (pt) Adoçante, método para a preparação e adoçante e aplicações do mesmo
BRPI0814986A2 (pt) Métodos e dispositivos para a distribuição de fármaco desmopresina.
BRPI0908092A2 (pt) Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
BRPI0914918A2 (pt) forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida.
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
BRPI0816513A2 (pt) Composição farmacêutica e método para preparar a suspensão sólida
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0916689A2 (pt) composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
BR112012006333A2 (pt) método para produzir um polímero à base de dieno conjugado modificado, polímero à base de dieno conjugado modificado, e, composição do mesmo.
BRPI1014700A2 (pt) composição de revestimento e método para a fabricação e uso da mesma.
DE502007005517D1 (de) Härtbare, dentale Massen
BRPI0908637A2 (pt) composto; composição farmacêutica do mesmo e método para inibição de proliferação celular em um indivíduo.
BRPI1011764A2 (pt) composição farmacêutica, e, método para preparar uma composição farmacêutica
BRPI0817917A2 (pt) Implemento para cuidado oral, e, método para formar um implemento para cuidado oral
BRPI0923880A2 (pt) Material de barreira a base de biopolímero e método para a obtenção do mesmo
BRPI0809573A8 (pt) composição, e, método

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SAMYANG HOLDINGS CORPORATION (KR)

B25A Requested transfer of rights approved

Owner name: SAMYANG BIOPHARMACEUTICALS CORPORATION (KR)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/12/2008, OBSERVADAS AS CONDICOES LEGAIS.

B25G Requested change of headquarter approved

Owner name: SAMYANG BIOPHARMACEUTICALS CORPORATION (KR)

B25A Requested transfer of rights approved

Owner name: SAMYANG HOLDINGS CORPORATION (KR)